immune control hiv- early treatment acute infection 
virus-specific t-helper cells considered critical control chronic viral infections12 successful treatment acute hiv- infection leads augmentation responses3- whether enhances immune control determined administered one two supervised treatment interruptions eight subjects treated acute infection plan restart therapy viral load exceeded copies hiv- rna per millilitre plasma level therapy typically recommended three consecutive weeks rna copies per ml one time show despite rebound viraemia subjects able achieve least transient steady state therapy viral load rna copies per ml present five eight subjects remain therapy viral loads less rna copies per ml plasma median months range - months observed increased virus-specific cytotoxic t lymphocytes maintained t-helper-cell responses data indicate functional immune responses can augmented chronic viral infection provide rationale immunotherapy hiv- infection 
